A New Chapter for More Than Blue – Now Streaming Worldwide
More Than Blue is now streaming globally across digital platforms including Amazon Prime Video, Apple TV, YoutubeTV, and Vimeo on Demand. Watch now!
Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?
New data reveal that while most women with postpartum depression start antidepressant treatment, many discontinue treatment early—highlighting persistent gaps in postpartum care.
Rapid Symptom Relief in Postpartum Psychosis with Brexanolone
An open-label pilot study suggests that intravenous brexanolone may rapidly reduce psychotic, manic, and depressive symptoms in patients with postpartum psychosis, highlighting a potential new treatment option.
Beyond the EPDS: Using AI to Identify Women at Risk for Postpartum Depression
AI and machine learning models, using tools like the EPDS and data from the electronic health record, may help clinicians detect and even prevent postpartum depression.
Can Esketamine Be Used to Prevent Postpartum Depression?
Emerging evidence suggests perioperative esketamine may reduce postpartum depression risk and improve recovery; however, information regarding long-term efficacy and optimal use is limited.
Sleep Problems During Pregnancy: Screening and Opportunities for Intervention
Early identification and treatment of maternal sleep problems during pregnancy may lower the risk for postpartum depression and improve both maternal and infant sleep outcomes.
Bringing More Than Blue Documentary Across The Globe
We are pleased to share that our More Than Blue documentary is now screening across the globe through our new partnership with ROCO films.
Task-Sharing: A Behavioral Activation Intervention for Perinatal Depression Could Expand Access to Care
Behavioral activation intervention, whether delivered by specialists or non-specialists, was effective for the treatment of perinatal depression and anxiety.
Behavioral Activation Reduces Suicidal Ideation in Women with Perinatal Depression
Behavioral activation significantly reduced suicidal ideation in women with perinatal depression, showing effectiveness whether delivered in-person or remotely by specialists and non-specialists.
Zuranolone and Breastfeeding: Emerging Data and Clinical Implications
Treatment with zuranolone, a novel oral antidepressant for postpartum depression, raises important questions for breastfeeding individuals. While recent studies show minimal transfer into breast milk, we do not yet have enough information to recommend breastfeeding while taking zuranolone.